Sirukumab Not Recommended for RA on Mortality Concerns Sirukumab Not Recommended for RA on Mortality Concerns

An FDA panel voted not to recommend sirukumab for adults with moderate-to-severe rheumatoid arthritis because of increased mortality in patients who took the drug in clinical trials.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news